Low avidity observed for anti-citrullinated peptide antibody is not a general phenomenon for autoantibodies

Ann Rheum Dis. 2023 Dec;82(12):1637-1638. doi: 10.1136/ard-2023-224303. Epub 2023 Jul 10.

Authors

Hisakata Yamada^{1

2

3}, Akihisa Haraguchi², Tomomi Tsuru⁴, Masakazu Kondo³, Fumiaki Sagawa⁴, Hiroaki Niiro⁵, Yasuharu Nakashima²

Affiliations

¹ Department of Clinical Immunology, Kyushu University Faculty of Medicine Graduate School of Medical Science, Fukuoka, Japan [email protected].
² Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
³ Kondo Clinic for Rheumatology and Orthopaedics, Fukuoka, Japan.
⁴ PS Clinic, Fukuoka, Japan.
⁵ Department of Medical Education, Kyushu University, Fukuoka, Japan.

PMID: 37433576
DOI: 10.1136/ard-2023-224303

No abstract available

Keywords: Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies.

Publication types

Letter

MeSH terms

Arthritis, Rheumatoid*
Autoantibodies*
Citrulline
Humans
Peptides
Peptides, Cyclic

Substances

Autoantibodies
Peptides
Peptides, Cyclic
Citrulline